Bronx CB7 Tackles Vaccine Concerns
On the pandemic front, the good news is that COVID-19 infection, hospitalization, and death rates are all decreasing statewide. In addition, the COVID-19 vaccine from Johnson & Johnson has been approved by the FDA, which now provides a third immunization option beyond Pfizer and Moderna, and one which requires just one vaccination dose rather than two. The bad news, however, is that throughout the country and especially within the boundaries of Bronx Community Board 7 (CB7), vaccination rates are alarmingly low. At the latest meeting of CB7’s Health & Human Services Committee on Feb.22, committee members looked
